Back to Search
Start Over
Zai Lab receives China NMPA approval for Optune for glioblastoma
- Source :
- The Fly. May 13, 2020
- Publication Year :
- 2020
-
Abstract
- Zai Lab Limited (ZLAB) and Novocure (NVCR) announced that the China National Medical Products Administration has approved the Marketing Authorization Application for Optune in combination with temozolomide for the treatment [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.623724665